What have been your most important steps and learnings so far?
There have been an enormous number of them. Probably the most important, however, was to never forget to always develop starting from the needs of the users. There is no other way to be close to the market, to stay as fast as possible and to observe regulation.
How did you approach the issues of financing and funding?
Until a few weeks ago, we were bootstrapped, i.e. revenue- and self-financed. We already had our first paying customers in 2018. We were also involved in several large research projects. This brought in additional funds, but above all, the close cooperation with universities and hospitals helped us to move forward. By now, we know where we can bring great medical benefits, where we can help save lives. And since we have realised this, we have decided to get investors on board, and we notice that there is a lot of interest.